SuperSonic promotes novel form of elastography
SuperSonic Imagine returned to the RSNA exhibit floor with FDA clearance to market its Aixplorer ultrasound system in the U.S.
SuperSonic Imagine returned to the RSNA exhibit floor with FDA clearance to market its Aixplorer ultrasound system in the U.S. The French company last year unveiled its software-based system along with its ShearWave Elastography technique as the means for differentiating benign and malignant lesions of the breast. Although the digital measurements that define the stiffness of these tissues can be displayed and interpreted on Aixplorer systems sold outside the U.S., the FDA-cleared version shows only B-mode color-coded images. These images show the relative stiffness or elasticity of tissue, which may help physicians distinguish among healthy tissue and benign and malignant tumors in the breast. The company is now developing applications for the thyroid and abdomen, which will define cancer as well as other diseases.
Aixplorer creates these images using algorithms developed for video games and multicore processors. The company's ShearWave Elastography differs from conventional, or strain, elastography, which relies on manual compression by the operator and is, therefore, dependent on operator skill. Instead, ShearWave elastography is operator-independent, using both ultrasound waves and shear waves to assess tissue stiffness.
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which was unveiled at the American College of Cardiology (ACC) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
